The Ki-67 index is an important prognostic marker in many types of cancer, including breast cancer, prostate cancer, and neuroendocrine tumors. High levels of Ki-67 are often associated with more aggressive tumors and poorer outcomes, as they indicate rapid cell proliferation. Conversely, lower levels of Ki-67 generally suggest a less aggressive tumor and a better prognosis.